Anticancer Effects of Midazolam on Lung and Breast Cancers by Inhibiting Cell Proliferation and Epithelial-Mesenchymal Transition

Despite improvements in cancer treatments resulting in higher survival rates, the proliferation and metastasis of tumors still raise new questions in cancer therapy. Therefore, new drugs and strategies are still needed. Midazolam (MDZ) is a common sedative drug acting through the γ-aminobutyric acid...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Hsin-Ling, Wu, King-Chuen, Chen, Char-Wen, Weng, Hong-Kai, Huang, Bu-Miin, Lin, Ting-Yu, Liu, Ming-Hsin, So, Edmund-Cheung, Lin, Ruey-Mo, Wang, Yang-Kao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703822/
https://www.ncbi.nlm.nih.gov/pubmed/34947927
http://dx.doi.org/10.3390/life11121396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703822/
https://www.ncbi.nlm.nih.gov/pubmed/34947927
http://dx.doi.org/10.3390/life11121396

Ejemplares similares